In 2021, sales of analgesics are returning to their usual performance following record growth in 2020 when consumers stockpiled analgesics during the COVID-19 pandemic. Adult naproxen remains the fastest growing category in 2021 as consumers are looking for products other than usual ibuprofen and it is still developing from a low base. The offerings in this category are limited and it remains a niche category largely benefitting from sales of the Nalgesin brand. The brand belongs to Krka dd Novo...

Euromonitor International’s Analgesics in Estonia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.